Socioeconomic disparity trends in diagnostic imaging, treatments, and survival for non‐small cell lung cancer 2007‐2016

by Monica Shah, Ambica Parmar, Kelvin K. W. Chan
Published 2020-05-01

Value‐based pricing: Toward achieving a balance between individual and population gains in health benefits

by Ambica Parmar, Tina Jiao, Ronak Saluja, Kelvin K. W. Chan
Published 2020-01-01

Comparing Manufacturer Submitted and Pan-Canadian Oncology Drug Review Reanalysed Incremental Cost-Effectiveness Ratios for Novel Oncology Drugs

by Ronak Saluja, Tina Jiao, Liza Koshy, Matthew Cheung, Kelvin K. W. Chan
Published 2021-01-01

Clinician Perspectives of COVID-19-Related Cancer Drug Funding Measures in Ontario

by Rohini D. Naipaul, Rebecca E. Mercer, Kelvin K. W. Chan, Lyndee Yeung, Leta Forbes, Scott Gavura
Published 2021-02-01

The effectiveness of rituximab and HIV on the survival of Ontario patients with diffuse large B‐cell lymphoma

by Steven Habbous, Helen Guo, Jaclyn Beca, Wei Fang Dai, Wanrudee Isaranuwatchai, Matthew Cheung, Kelvin K. W. Chan
Published 2020-10-01

Poor recognition of risk factors for hepatitis B by physicians prescribing immunosuppressive therapy: a call for universal rather than risk-based screening.

by Alissa Visram, Kelvin K W Chan, Phyllis McGee, Jordana Boro, Lisa K Hicks, Jordan J Feld
Published 2015-01-01

Systemic therapy in the curative treatment of head and neck squamous cell cancer: a systematic review

by Eric Winquist, Chika Agbassi, Brandon M. Meyers, John Yoo, Kelvin K. W. Chan, the Head and Neck Disease Site Group
Published 2017-04-01

The impact of pricing strategy on the costs of oral anti‐cancer drugs

by Judy Truong, Kelvin K. W. Chan, Helen Mai, Alexandra Chambers, Mona Sabharwal, Maureen E. Trudeau, Matthew C. Cheung
Published 2019-07-01

A Systematic Review and Network Meta-Analysis of Biologic Agents in the First Line Setting for Advanced Colorectal Cancer.

by Alexander Kumachev, Marie Yan, Scott Berry, Yoo-Joung Ko, Maria C R Martinez, Keya Shah, Kelvin K W Chan
Published 2015-01-01

Cost-effectiveness analysis of treatment with non-curative or palliative intent for hepatocellular carcinoma in the real-world setting.

by Hla-Hla Thein, Yao Qiao, Ahmad Zaheen, Nathaniel Jembere, Gonzalo Sapisochin, Kelvin K W Chan, Eric M Yoshida, Craig C Earle
Published 2017-01-01

Anticancer drugs approved by the Food and Drug Administration for gastrointestinal malignancies: Clinical benefit and price considerations

by Di Maria Jiang, Kelvin K. W. Chan, Raymond W. Jang, Christopher Booth, Geoffrey Liu, Eitan Amir, Robert Mason, Louis Everest, Elena Elimova
Published 2019-04-01

Estimates and predictors of health care costs of esophageal adenocarcinoma: a population-based cohort study

by Hla-Hla Thein, Nathaniel Jembere, Kednapa Thavorn, Kelvin K. W. Chan, Peter C. Coyte, Claire de Oliveira, Chin Hur, Craig C. Earle
Published 2018-06-01

Trajectory of End-of-Life Pain and Other Physical Symptoms among Cancer Patients Receiving Home Care

by Hsien Seow, Dawn M. Guthrie, Tara Stevens, Lisa C. Barbera, Fred Burge, Kimberlyn McGrail, Kelvin K. W. Chan, Stuart J. Peacock, Rinku Sutradhar
Published 2021-04-01

Real-world comparative effectiveness of second-line ipilimumab for metastatic melanoma: a population-based cohort study in Ontario, Canada

by Wei Fang Dai, Jaclyn M. Beca, Ruth Croxford, Wanrudee Isaranawatchai, Ines B. Menjak, Teresa M. Petrella, Nicole Mittmann, Craig C. Earle, Scott Gavura, Timothy P. Hanna, Kelvin K.W. Chan
Published 2020-04-01

Real-World Cost-Effectiveness of Bevacizumab With First-Line Combination Chemotherapy in Patients With Metastatic Colorectal Cancer: Population-Based Retrospective Cohort Studies i...

by Reka E. Pataky, Jaclyn Beca, David Tran, Wei Fang Dai, Erind Dvorani, Wanrudee Isaranuwatchai, Stuart Peacock, Riaz Alvi, Winson Y. Cheung, Craig C. Earle, Scott Gavura, Kelvin K. W. Chan
Published 2021-06-01

Longitudinal assessment of right ventricular structure and function by cardiovascular magnetic resonance in breast cancer patients treated with trastuzumab: a prospective observati...

by Ashita Barthur, Christine Brezden-Masley, Kim A. Connelly, Vinita Dhir, Kelvin K. W. Chan, Rashida Haq, Anish Kirpalani, Joseph J. Barfett, Laura Jimenez-Juan, Gauri R. Karur, Djeven P. Deva, Andrew T. Yan
Published 2017-04-01

Ambulatory Toxicity Management (AToM) Pilot: results of a pilot study of a pro-active, telephone-based intervention to improve toxicity management during chemotherapy for breast ca...

by Monika K. Krzyzanowska, Cassandra MacKay, Heekyung Han, Maria Eberg, Sonal Gandhi, Nicole B. Laferriere, Melanie Powis, Doris Howell, Clare L. Atzema, Kelvin K. W. Chan, Vishal Kukreti, Sandra Mitchell, Marla Nayer, Mark Pasetka, Dafna Knittel-Keren, Erin Redwood
Published 2019-03-01

Real‐world outcomes of FOLFIRINOX vs gemcitabine and nab‐paclitaxel in advanced pancreatic cancer: A population‐based propensity score‐weighted analysis

by Kelvin K. W. Chan, Helen Guo, Sierra Cheng, Jaclyn M. Beca, Ruby Redmond‐Misner, Wanrudee Isaranuwatchai, Lucy Qiao, Craig Earle, Scott R. Berry, James J. Biagi, Stephen Welch, Brandon M. Meyers, Nicole Mittmann, Natalie Coburn, Jessica Arias, Deborah Schwartz, Wei F. Dai, Scott Gavura, Robin McLeod, Erin D. Kennedy
Published 2020-01-01